Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    661
  • comments
    0
  • views
    2,129

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The gene therapy market is estimated to be worth USD 11.6 billion in 2030: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.   The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies and genome editing therapies. The study also features an elaborate discussion on the future potential of this evolving market. In addition to other elements, the study includes:

The “In Silico / Computer-Aided Drug Discovery Services Market: RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html   Key Inclusions §  A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules, including information on year of establishment, company size, location of headquarters, type of business model used (contract service providers (CROs), software / technology providers, consulting service providers and training service providers), number of dr

Over 90 firms are actively involved in providing in silico services for drug{RootsAnalysis}

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.   To order this 290+ page report, which features 120+ figures and

In silico drug discovery services market is likely to be worth USD 124 million by 2030{Roots}

Roots Analysis has done a detailed study on “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery / Multi-Target Drug Design, Interface Based Drug Discovery, Approaches)” covering key aspects of the industry’s evolution and identifying potential future g

In silico drug discovery services market is likely to be worth USD 124 million by 2030(RootsAnalysis)

Roots Analysis is pleased to announce the publication of its recent study, titled, “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery / Multi-Target Drug Design, Interface Based Drug Discovery, Approaches).”   The  report features an extensi

In silico drug discovery services market is likely to be worth USD 124 million by 2030(Roots)

Roots Analysis has announced the addition of “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery / Multi-Target Drug Design, Interface Based Drug Discovery, Approaches)” report to its list of offerings.   Presently, in silico tools / approac

The ‘‘Drug Repurposing Service Providers Market, 2020-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html   Key Inclusions §  A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant parameters, including year of establishment, company size, location of headquarters, type of company, type of service offered (drug discovery, consulting and others), purpose of repurposing, type of repurposing and technology platform used. §  A detailed

Presently, over 65 companies claim to offer drug repurposing-related services<Roots>

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).   To order this 250+ page report, which feat

The drug repurposing service providers market is projected to grow at an annualized rate: RootsAnalysis:

Roots Analysis has done a detailed study on Drug Repurposing Service Providers Market, 2020-2030. covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html   Key Market Insights §  More than 60 industry players across the world are presently engaged in

The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study

The ‘Medical Device CROs Market (2nd Edition), 2020-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html   Key Inclusions §  A detailed review of the overall landscape of medical device CROs, along with information on year of establishment, company size, location of headquarters, type of service offered by [A] clinical service providers  (biostatistics, consulting, clinical operations, post marketing surveillance / studies, quality assurance, regulatory affairs management, reimbursement and train

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range{Roots}

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.   To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanal

The medical device CRO market is projected to grow at an annualized rate of 6.4%(RootsAnalysis)

Roots Analysis has done a detailed study on “Medical Device CRO Market (2nd Edition), 2020-2030”. covering various important aspects of the industry and identifying key future growth opportunities.   To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/medical-device-cros-market/226.html   Key Market Insights §  Since 2015, over 7,500 medical device focused clinical trials,

The medical device CRO market is estimated to be worth USD 15.7 billion in 2030(Roots)

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”.   The report features an extensive study of the current market landscape and future opportunities of contract research service providers focused on medical devices. The study also features an in-depth analysis, highlighting the capabilities of the various stakeholders engaged in this domain, across different regions of the globe. In addition to other

The ‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html   Key Inclusions §  A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating t

Currently, there are over 240 closures, fabricated using a variety of elastomeric materials<Roots>

The materials used to fabricate pharmaceutical packaging components are extremely important to preserving the stability, efficacy and safety of drug formulations. In fact, according to the USFDA, in the last two years, there have been over 2,000 drug and device recalls owing to packaging-related concerns. Elastomeric closures, with various types of coatings (such as FluoroTec® and Teflon®), have emerged as a promising option for developing closures for pharmaceutical containers.   To o

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030: By RootsAnalysis:

Roots Analysis has done a detailed study on Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 400+ page report, which features 185+ figures and 235+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html   Key Market Ins

The elastomeric closures market is projected to reach USD 9.3 Billion by 2030: By Roots:

Roots Analysis is pleased to announce the publication of its recent study, titled, “Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030.”   The report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various typ

Human Microbiome Market: Focus on Therapeutics (including gut-brain axis:RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html   Key Inclusions §  A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, location of headquarters and company size), clinical study sponsor(s) or collaborators, phase of development (clinical, preclinical, and discovery stage) of product candidates, type of molecule (small molecule and

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages: Roots:

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030{RootsAnalysis}

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.   To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html   Key Market Insights §  Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the U

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030{Roots}

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings   The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: §  A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s). §  Elaborate profiles of key players (established afte

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030(RootsAnalysis)

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings.   The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. How

The “Global Handheld X-Ray Imaging Devices Market by Area of Application(Roots)

https://www.rootsanalysis.com/reports/handheld-x-ray-imaging-devices-market.html   Key Inclusions §  An overview of the current market landscape of the handheld X-ray imaging devices, providing information on the status of development (developed and under development), area of application (dental, orthopedic and others), weight of device, size of focal spot, tube voltage, type of battery used (lithium ion and lithium polymer), battery voltage, exposure time, battery efficiency and

Several players are currently engaged in the development / manufacturing of handheld<RootsAnalysis>

The applications of handheld imaging devices in modern healthcare are vast, spanning almost all major medical disciplines, from dentistry to cardiology, covering several internal organs across various parts of the body, such as the chest, and abdomen / gastrointestinal tract. In this context, it is worth mentioning that over the past couple of months, multiple studies have described the use of handheld X-ray devices in diagnosing symptoms of the novel coronavirus infection in patients, worldwide
×
  • Create New...